1）Sato Y , Hirakawa M , Ohnuma H , Takahashi M , Okamoto T , Okamoto K , Miyamoto H , Muguruma N , Furuhata T , Takemasa I , Kato J , Takayama T
A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study.
Cancer Chemother Pharmacol. 2017, in press.
2）Otsuka M, Shiratori M, Chiba H, Kuronuma K, Sato Y, Niitsu Y, Takahashi H.
Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes.
Experimental Lung Research. 2017, in press
